PARACOCCUS DENITRIFICANS IRON TRANSPORT APPARATUS
副球菌脱氮铁转运装置
基本信息
- 批准号:3286718
- 负责人:
- 金额:$ 10.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-04-01 至 1992-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This program will focus on the bioorganic chemistry of ferric
parabactin processing by Paracoccus denitrificans, i.e., the
microorganism's iron uptake apparatus. Special emphasis will be
placed on the role of the ferric parabactin receptor. Our studies
to date have revealed that 1) the kinetics of ferric parabactin
promoted iron uptake are consistent with a "Taxi Cab" mechanism
in which ferric parabactin is adsorbed to the surface of the
microorganism, the iron liberated and the deferrated ligand
released; 2) the microorganism has an 80kD outer membrane
protein inducible by iron starvation that binds ferric L-parabactin
with an apparent Kd of 0.7uM, a protein which we have
substantially purified; 3) this protein does not release iron from
ferric parabactin by itself; and 4) the photoaffinity label, ferric
L-parabactin azide can be utilized to label the ferric parabactin
receptor protein.
With these findings in hand and with the techniques we have
developed, we will address the following questions, questions
which although not exclusively, are largely focused on the role on
the ferric parabactin receptor. 1) How substrate specific is the
ferric parabactin receptor? 2) Is deferrated ferric parabactin
released as intact parabactin? 3) How is iron liberated from
ferric parabactin after it has been bound to the receptor? 4)
What structural features of the receptor protein are critical to
ferric parabactin processing, i.e., what are the key structural
components of the protein responsible for binding?
The relevance of the ferric parabactin receptor protein is in part
associated with the a recent interest in utilizing these surface
expressed proteins in the development of vaccines for
opportunistic bacteria. Unfortunately, little is known about the
isolation and properties of these siderophore receptors, a situation
which this program will alleviate at least in part.
本课程将着重于铁的生物有机化学
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raymond Joseph Bergeron其他文献
Raymond Joseph Bergeron的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raymond Joseph Bergeron', 18)}}的其他基金
Desferrithiocin Analogue Actinide Decorporation Agents
去铁硫星类似物锕系装饰剂
- 批准号:
7586364 - 财政年份:2006
- 资助金额:
$ 10.75万 - 项目类别:
Desferrithiocin Analogue Actinide Decorporation Agents
去铁硫星类似物锕系装饰剂
- 批准号:
7267878 - 财政年份:2006
- 资助金额:
$ 10.75万 - 项目类别:
ORAL IRON CHELATORS PREDICATED ON DESFERRITHIOCIN
基于去铁硫辛的口服铁螯合剂
- 批准号:
2654532 - 财政年份:1995
- 资助金额:
$ 10.75万 - 项目类别:
ORAL IRON CHELATORS PREDICATED ON DESFERRITHIOCIN
基于去铁硫辛的口服铁螯合剂
- 批准号:
2149704 - 财政年份:1995
- 资助金额:
$ 10.75万 - 项目类别:
相似海外基金
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
- 批准号:
10374792 - 财政年份:2021
- 资助金额:
$ 10.75万 - 项目类别:
Elucidation and prevention of the mechanism of hepatic sinusoidal obstruction syndrome (SOS) induced by DNA alkylating agents
DNA烷化剂诱发肝窦阻塞综合征(SOS)机制的阐明和预防
- 批准号:
21K15255 - 财政年份:2021
- 资助金额:
$ 10.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
- 批准号:
10570900 - 财政年份:2021
- 资助金额:
$ 10.75万 - 项目类别:
Development of individualized therapy by elucidation of molecular mechanisms for hypermutation phenotype induced by treatment with alkylating agents in glioma
通过阐明神经胶质瘤中烷化剂治疗诱导的超突变表型的分子机制来开发个体化治疗
- 批准号:
18K09004 - 财政年份:2018
- 资助金额:
$ 10.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Reversing intrinsic cancer cell resistance to alkylating agents by histone deacetylase inhibition
通过组蛋白脱乙酰酶抑制逆转癌细胞对烷化剂的内在耐药性
- 批准号:
214657440 - 财政年份:2012
- 资助金额:
$ 10.75万 - 项目类别:
Research Grants
Rerouting alkylating agents to the mitochondria for cancer therapy
将烷化剂重新路由至线粒体用于癌症治疗
- 批准号:
247842 - 财政年份:2011
- 资助金额:
$ 10.75万 - 项目类别:
Studentship Programs
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8105413 - 财政年份:2010
- 资助金额:
$ 10.75万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8271313 - 财政年份:2010
- 资助金额:
$ 10.75万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8730259 - 财政年份:2010
- 资助金额:
$ 10.75万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8676463 - 财政年份:2010
- 资助金额:
$ 10.75万 - 项目类别:














{{item.name}}会员




